Earlier this week, San Diego startup Gallant announced $18 million in funding to bring the first FDA-approved ready-to-use stem cell therapy to veterinary medicine. If it passes regulatory muster ...

Cellares grows in NJ and globally with Smart Factories and key partnerships to advance scalable, cost-effective cell therapy manufacturing.

Dr. Andre Henri Goy shared how CAR T-cell therapy led a retired pilot with lymphoma into remission, showing the impact of personalized treatment decisions.

CHICAGO — A single infusion of zimislecel, an investigational stem cell-based therapy, restored physiologic islet function and conferred improved outcomes and insulin independence at 1 year ...

Zemcelpro provides an option for people with a hematologic malignancy who need a blood stem cell transplant but have no suitable donor.

Following a disappointing performance from the company’s CAR-T candidate in an early-stage cancer trial, BioNTech is winding down cell therapy manufacturing at its inaugural U.S. plant.

AstraZeneca's experimental CAR-T cell therapy put a handful of lupus patients into remission, with six out of ten patients showing no signs of the disease nine months after a one-time infusion ...

Leaders from the world of cell and gene therapy shared their personal stories and policy recommendations in an extraordinary roundtable conducted by the FDA in front of its recently-appointed top ...

New gene therapy improves the life of 18-year-old with Sickle Cell Disease which affects 5,000 New Jersey residents living with the condition.

Read about a CAR T cell therapy that appears effective against light chain (AL) amyloidosis.

This first-in-class stem cell therapy is designed to stimulate the activation and maintenance of stem cells in regenerative regions of the brain while reducing inflammation.

A recent article in Science Immunology, by Dr. Adam Courtney and others, indicated that the herpes virus can improve immune cell activity by promoting proteins that aid in immune cell survival.